慢病毒转染肝细胞方法
| Lentivirus Transduction of Hematopoietic Cells | |
| Ming-Jie Li and John J. Rossi Division of Molecular Biology, Beckman Research Institute of the City of Hope, Duarte, California 91010 Excerpted from Gene Transfer: Delivery and Expression of DNA and RNA Edited by Theodore Friedmann and John Rossi | |
| ABSTRACT |
| Efficient transfer and sustained expression of transgenes are among the most important issues in gene delivery technologies. The majority of hematopoietic cells, including hematopoietic stem/progenitor cells and terminally differentiated cells, such as primary T cells and macro phages, are nondividing or slowly self-renewing. These cell types are refractory to most nonviral or retroviral delivery methods. Lentiviral vectors are capable of transducing nondividing cells and maintaining long-term and sustained expression of the transgenes. Many hematopoietic cell types have been successfully transduced with lentiviral vectors carrying a variety of genes. Lentiviral vectors are becoming useful for many delivery protocols, such as long-term expression of short hairpin RNA (shRNA) and functional genetics. They may also have great potential in gene therapy. This protocol describes lentivirus-vector-based delivery of foreign genes to hematopoietic cells. The method is applicable to various cell types in experiments that require long-term transgene expression. |
| MATERIALS |
| Reagents |
|
| Equipment |
|
| METHOD |
| Production of Lentiviral Vectors: Packaging of the Vectors
Maintain 293T cells in complete culture medium in a 37°C incubator with 5% CO2. Twenty-four hours before transfection, plate exponentially growing 293T cells in 100-mm tissue culture dishes at 4 x 106 cells/plate. Prepare 1 ml of calcium phosphate-DNA suspension for each 100-mm plate of cells as follows:
Mix the precipitate well by pipetting or vortexing Add 1 ml of the suspension to a 100-mm plate containing cells. Add the suspension slowly, dropwise while gently swirling the medium in the plate. Return the plates to the 37°C incubator and leave the precipitate for 4 hours. Replace the old medium with 6 ml of fresh culture medium. Add 60 µl of 0.6 M sodium butyrate. Return to the incubator. After 48 hours of culture, collect the supernatant and freeze it at -80°C or proceed to the concentration step. Centrifuge the supernatant (freshly collected or thawed from the freezer) at 900g for 10 minutes to remove any cell debris in the supernatant. Filter the supernatant through a 0.2-µm syringe filter. Transfer the supernatant to autoclaved polyallomer tubes. Concentrate the supernatant by ultracentrifugation for 1.5 hours at 4°C in a Beckman SW 28 swinging bucket rotor at 24,500 rpm. Remove the supernatant and resuspend the pellet in an appropriate amount of culture medium, e.g., 300 µl for 30 ml of original supernatant if a 100-fold concentration is desired. Divide the concentrated vector into 10-50-µl aliquots and store at -80°C until use. Seed 5 x 104 HT1080 cells/well in a 12-well plate in complete medium and culture overnight in a 37°C incubator with 5% CO2. Add serial diluted vector stock and 4 µl/ml polybrene to the cultured cells. Continue culture for 48 hours. Trypsinize the cells. Following centrifugation, remove the supernatant and resuspend the pellet in 300 µl of 3.7% formaldehyde in PBS. Determine the percentage of EGFP-positive cells by FACS analysis. 
Seed exponentially growing cells at 2 x 105 cells/well in 1 ml of culture medium into a 24-well plate. Add various amounts of concentrated vector stock depending on cell type. For the K562 cell line (CML leukemia cell line), a multiplicity of infection (moi) of 10 can achieve virtually 100% transduction. Add 4 µg/ml polybrene. Return the cells to a 37°C incubator. After overnight incubation, centrifuge the cells, discard the supernatant, and resuspend the cells with fresh culture medium. Return the cells to culture. Determine transduction efficiency by FACS analysis 48 hours after transduction (see Troubleshooting). Purify CD34+ hematopoietic stem cells from umbilical cord blood or bone marrow using anti-CD34 antibody-coupled magnetic beads following the manufacturer's protocol. Forty-eight hours before transduction, culture the CD34+ cells in CD34+transduction medium. Coat a 48-well nontissue-culture-treated plate with 0.2 ml of 25 µg/ml RetroNectin (~5 µg/cm2) for 2 hours at room temperature Remove RetroNectin and then add 0.2 ml of 2% BSA in PBS for blocking. Store the plate for 30 minutes at room temperature. After washing the wells with PBS, adjust the lentiviral vector stock to the appropriate moi (range 5-40) with plain IMDM medium to 200-µl volume and load it into the well of the coated plate. After incubation for 2 hours at 37°C, remove the vector supernatant and then wash the well with PBS. Add the prestimulated CD34+ cells to the well at 1 x 105 cells/well in 0.2 ml of growth medium and return the cells to the 37°C incubator. After overnight culture, centrifuge the cells, resuspend the cell pellet in 1 ml of culture medium, and transfer the cells to a 24-well plate. Return the cells to the incubator. Determine transduction efficiency by FACS analysis 6 days after transduction. |
| TROUBLESHOOTING |
| Problem (Step 20): Some cell types, such as CEM (a human T cell line), are difficult to transduce by the standard protocol. Solution: For those cell types that resist transduction by normal means, centrifugation can substantially enhance the transduction efficiency. Treat these cells as follows. Combine 2 x 105 cells in 1 ml of culture medium in a 15-ml centrifuge tube with vector and 4 µg/ml polybrene. Centrifuge at 900g for 30 minutes at 20°C. Then, without removing the supernatant, use a pipette to resuspend the cell pellet and transfer the cells to the culture plate. Incubate the cells overnight, replace the medium, and continue the culture. |
| ACKNOWLEDGMENTS |
| We thank Dr. Jiing-Kaun Yee for providing pHIV7-GFP and the packaging plasmids. The authors were supported by National Institutes of Health grants AI29329, AI42552, and HL074704. |
| Anyone using the procedures in this protocol does so at their own risk. Cold Spring Harbor Laboratory makes no representations or warranties with respect to the material set forth in this protocol and has no liability in connection with the use of these materials. Materials used in this protocol may be considered hazardous and should be used with caution. For a full listing of cautions regarding these material, please consult: Gene Transfer: Delivery and Expression of DNA and RNA, A Laboratory Manual, edited by Theodore Friedmann and John Rossi, © 2006 by Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, p. 75-82. |
| Copyright © 2006 by Cold Spring Harbor Laboratory Press. All rights reserved. No part of these pages, either text or image may be used for any purpose other than personal use. Therefore, reproduction modification, storage in a retrieval system or retransmission, in any form or by any means, electronic, mechanical, or otherwise, for reasons other than personal use, is strictly prohibited without prior written permission. |
